5+ years of experience
Concerned about your lack of experience? Learn More...
Employment Type:
Full time
Job Category:
See more jobs for students and recent grads who studied:
Regional Market Access Manager/Key Account Manager, Market Access, Norway
Biogen | Oslo, Minnesota
Tell Us More About Your Job Preferences
By telling us what you think of this job, we can help find jobs that match your interests. If you want to see more jobs like this, click on the smiley face. Or if this job isn't what you are looking for, click the frowny face. Learn More...

Follow This Company

Job Description

External Posting TitleRegional Market Access Manager/Key Account Manager, Market Access, Norway
Job DescriptionThe Regional Field Market Access/ Key Account Manager:

•Manages market access conditions in prioritized hospitals and regional health trusts such that Biogen's products are accessible to meet the medical needs of patients

•Maps the conditions (financial, organizational, etc.) and stakeholders that decisively influence access to Biogen's products

•Ensure that market access tools are adopted to be maximally relevant to stakeholders at the level of hospitals

•In alignment with sales/medical/marketing develop access strategies and tactics for prioritized hospitals and health trusts

•Executes activities that engage key stakeholders at the level of hospitals

•Undertake activities and projects with local budget holders to realize the value proposition between BBU and originals

Accountabilities include:
a. The Regional Field Market Access/ Key Account Manager: is responsible of being the main expert of prioritized hospitals and health trusts with respect to conditions (financial and organizational) and stakeholders influencing the access conditions for Biogen's products. The Regional Field Market Access/ Key Account Manager keeps an updated stakeholder map and researches the main issues and developments for each prioritized hospitals and health trusts. In alignment with sales/medical/marketing, the (senior) market access manager builds an access plan/stakeholder plan with key objectives and tactics for each prioritized hospitals and health trusts.
The Regional Field Market Access/ Key Account Manager: is the general expert on Field Market Access strategies and tactics.

b. The Regional Field Market Access/ Key Account Manager: ensures that the market access tools, presentations, budget impact models that are developed by market access are highly relevant to stakeholders at hospitals. The Regional Field Market Access/ Key Account Manager is responsible of adapting and optimizing all materials to the needs of each activity/stakeholder interaction.
The Regional Field Market Access/ Key Account Manager: develops new business concepts for field market access.
c. The Regional Field Market Access/ Key Account Manager: manages hospital stakeholders at higher levels such as clinic heads, payer networks and decision making bodies in health trusts, local patient advocates, etc. to secure access to our medicines e.g. value communication to horizon scanning groups to ensure early awareness of BIIB MS franchise pipeline and thus to manage hospital funding issues e.g. closely collaborate with clinic heads giving them tools and arguments to raise awareness of neurology and cost of illness of MS, aiming at driving resources to neurology and increasing MS clinics budgets through horizontal prioritizations within county councils.

The Regional Field Market Access/ Key Account Manager: coordinates across functions in order to increase the effectiveness of the regional access work taking place.

d. The Regional Field Market Access/ Key Account Manager: manager proactively discusses tenders with key stakeholders within county councils.
The Regional Field Market Access/ Key Account Manager: manager builds strong relationships with BIIB Regional Market access, the BIIB global market access network, affiliate-level partners to be aligned on global, regional and local strategies.

LocationOslo, Norway
Job CategoryCommercial Operations, Sales & Marketing, Market Access
Requisition Number30189BR
• Minimum 5 years of biotech/pharmaceutical experience in a Market Access role.

• We will expect a good understanding and experience of work with regional decision making bodies and payer groups, health economics/outcomes projects.

• Specific knowledge of the Norwegian health care system and life science experience is a prerequisite

• Strong drive

• Strong Influence/Persuasion/Negotiation skills
Excellent communication/Interpersonal skills

• Excellent analytical skills

• Strong commercial attitude

• Strong business acumen

• Proactive

• Strong collaborator and ability to create stakeholder trust at different levels in the Health Care system

• Fluent in Norwegian & English is essential
• Master's degree is strongly preferred in a science/analytic field or health care professional. The Market Access manager should have deep knowledge in health economics and related fields. It is critical that the (Senior) Market Access Manager easily can shift gears between lines of reasoning based on health economics, medical science and knowledge of local financial/organizational and political priorities.
About BiogenThrough cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.

With more than 7,000 people worldwide, Biogen is truly a global organization. We are headquartered in Cambridge, Massachusetts, which is home to our research operations. Our international operations are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. With a strong affiliate presence and a network of distribution partners, Biogen has established a global footprint that allows us to capture the greatest value for the products we develop.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Please be advised that all legitimate correspondence from a Biogen employee will come from "@biogen.com" email accounts.

About Biogen

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company's products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab) and FUMADERM (dimethylfumarate and monoethylfumarate salts). AVONEX is used in the treatment of relapsing forms of multiple sclerosis (MS). RITUXAN is used in the treatment of relapsed or refractory low-grade or follicular, CD20-positive, and B-cell, non-Hodgkin's lymphomas (B-cell NHLs). TYSABRI is approved for the treatment of relapsing forms of MS. FUMADERM acts as an immunomudulator. It also has product candidates, such as BG-12 (acquired with the purchase of Fumapharm), ANTI-CD80 antibody/(galiximab), ANTI-CD23 antibody/(lumiliximab), Ocrelizumab/(Humanized ANTI-CD20 Antibody) and Lixivaptan.In January 2007, the Company completed the acquisition of Syntonix Pharmaceuticals, Inc. (Source: 10-K)

This company profile was created by AfterCollege and is about Biogen. This page is not endorsed by or affiliated with Biogen. For questions regarding company profiles, please email: care@aftercollege.com.